Key facts
- Multiwave’s last known valuation is $28.4M (Nov 2016).
- It has raised $14.1M; the latest was Later Stage VC ($4.4M) in Sep 2025.
- Notable investors include YADAY, Ava Investors, Fongit, French Government, Horizon 2020 — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Multiwave
- ·The full record, as it builds
Funding rounds
No funding rounds for Multiwave are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Multiwave
Operator of a deep science medical imaging company intended to develop a portable magnetic resonance imaging device. The company develops medical devices to improve the quality of imaging in magnetic resonance imaging and uses quantitative portfolio analysis and sensors to assist retailers' purchasing decisions, enabling clients to treat neurological conditions and get a guide for their overall marketing strategies to maximize profits.
- Sector
- Healthcare
- HQ
- Geneva, Switzerland
- Founded
- 2015
- Employees
- 17
- Website
- multiwave.ch/
- Ownership
- Privately Held (backing)
Multiwave doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Multiwave shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Multiwave in its N-PORT filings yet. We sweep new filings monthly.